Tao Synergies Inc stock is traded at $2.25, with a volume of 83,249. It is down -11.42% in the last 24 hours and down -38.86% over the past month. TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
Previous Close:
$2.54
Open:
$2.46
24h Volume:
83,249
Relative Volume:
0.69
Market Cap:
$18.10M
Revenue:
$687.80K
Net Income/Loss:
-$24.87M
P/E Ratio:
-
EPS:
-$13.42
Net Cash Flow:
-$34.22M
1W Performance:
-11.42%
1M Performance:
-38.86%
6M Performance:
-60.53%
1Y Performance:
-65.70%
1-Day Range:
$2.23$2.50
1-Week Range:
$2.23$2.78
52-Week Range:
$2.17$8.03
Tao Synergies Inc Stock (TAOX) Company Profile
Name
Tao Synergies IncSector
FinancialIndustry
Capital MarketsPhone
(973) 242-0005Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS